| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Colitis | D003092 | 69 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
| Carcinoma, Hepatocellular | D006528 | 140 associated lipids |
| Seizures | D012640 | 87 associated lipids |
| Carcinoma, Non-Small-Cell Lung | D002289 | 72 associated lipids |
Oroxylin A
Oroxylin A is a lipid of Polyketides (PK) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 747 references associated with Oroxylin A in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for Oroxylin A
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Oroxylin A
NCBI Entrez Crosslinks
All references with Oroxylin A
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Zhang Q et al. | Determination of oroxylin A and oroxylin A 7-O-d-glucuronide in HepG2 cell lysate and subcellular fractions with SPE-UPLC-MS/MS: Cellular pharmacokinetic study to indicate anti-cancer mechanisms. | 2018 | J Pharm Biomed Anal | pmid:29571134 |
| Chen W et al. | Activation of autophagy is required for Oroxylin A to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation. | 2018 | Int. Immunopharmacol. | pmid:29414645 |
| Jin H et al. | Oroxylin A inhibits ethanol-induced hepatocyte senescence via YAP pathway. | 2018 | Cell Prolif. | pmid:29318697 |
| Jin J et al. | Oroxylin A suppresses influenza A virus replication correlating with neuraminidase inhibition and induction of IFNs. | 2018 | Biomed. Pharmacother. | pmid:29091888 |
| Wu SC et al. | Baicalin protects mice against Salmonella typhimurium infection via the modulation of both bacterial virulence and host response. | 2018 | Phytomedicine | pmid:30195877 |
| Zhang C et al. | Oroxylin A prevents angiogenesis of LSECs in liver fibrosis via inhibition of YAP/HIF-1α signaling. | 2018 | J. Cell. Biochem. | pmid:28857294 |
| Shimizu T et al. | Synergistic effect of baicalein, wogonin and oroxylin A mixture: multistep inhibition of the NF-κB signalling pathway contributes to an anti-inflammatory effect of Scutellaria root flavonoids. | 2018 | J Nat Med | pmid:28921127 |
| Jin H et al. | Oroxylin A prevents alcohol-induced hepatic steatosis through inhibition of hypoxia inducible factor 1alpha. | 2018 | Chem. Biol. Interact. | pmid:29476730 |
| Chassagne F et al. | A metabolomic approach to identify anti-hepatocarcinogenic compounds from plants used traditionally in the treatment of liver diseases. | 2018 | Fitoterapia | pmid:29477305 |
| Zhang R et al. | Catechol-O-Methyltransferase and UDP-Glucuronosyltransferases in the Metabolism of Baicalein in Different Species. | 2017 | Eur J Drug Metab Pharmacokinet | pmid:28536775 |